Choroideremia Treatment Market Research 2024: Gene Therapy, Topical Carbonic Inhibitor, Dorzolamide, Lutein, Luxturna - Global Forecast to 2030
September 11, 2024 10:15 ET
|
Research and Markets
Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Choroideremia Treatment Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Treatment Type, Distribution Channel, Route...
Ophthalmic Drugs Strategic Business Report 2023-2030: Demand for OTC Eye Medications, and Increasing Global Incidence of Eye Diseases Like Glaucoma and AMD Bolsters the $56 Billion Market
August 16, 2024 09:19 ET
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Ophthalmic Drugs...
Ophthalmic Pharmaceutical Drugs Business Report 2024: Adoption of Biologics and Biosimilars Spurs Growth - Forecast to 2030
August 06, 2024 10:16 ET
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Global Macular Degeneration Testing and Therapeutics Market Poised for Growth, Expected to Reach US$14.959 Billion by 2029
August 02, 2024 06:35 ET
|
Research and Markets
Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Macular Degeneration Testing and Therapeutics Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering....
Comprehensive Report on ILUVIEN for Autoimmune Uveitis Reveals Market Size, Insights, and Forecast to 2032 in Key European Markets
July 17, 2024 05:26 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "ILUVIEN Market Size, Forecast, and Market Insight - 2032 (Germany, France, Italy,Spain and the United Kingdom)" report has been added to ...
Stargardt Disease Drug Pipeline Research 2024: Therapeutic Assessment by Product Type, Stage, Route of Administration, and Molecule Type
June 26, 2024 09:09 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Stargardt Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Allergic Conjunctivitis Market Research 2024-2032 with Focus on North America
June 25, 2024 10:03 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Global Allergic Conjunctivitis Market Report by Disease Type, Drug class, Distribution Channel, Countries and Company Analysis, 2024-2032" report has...
Global Juvenile Macular Degeneration Clinical Trials Review 2024, Featuring Lin Bioscience, Nanoscope Therapeutics, Alnylam Pharmaceuticals, Biophytis, Kubota Pharmaceutical and Nucleus Network
May 27, 2024 05:00 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Global Uveitis Treatment Research Report 2024: Market to Reach $1.34 Billion by 2034, Fueled by Increased Prevalence, Treatment Improvements, and Strategic Alliances & Collaborations
May 16, 2024 10:30 ET
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Global Uveitis Treatment Market" report has been added to ResearchAndMarkets.com's offering.The global uveitis treatment market accounted for USD 753...
Uveitis Treatment Market and Competitive Landscape Report, 2024: Analysis of Growth Opportunities by Drug Class, Disease Type, Distribution Channel, and Region to 2030
May 16, 2024 07:11 ET
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Uveitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...